PDL BioPharma (PDLI) Updates Q310 Outlook; Sees Revs Above Street Consensus
Tweet Send to a Friend
PDL BioPharma, Inc. (Nasdaq: PDLI) updates Q310 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
